Tamsulosin for Preventing Catheter Use After Urogynecology Surgery

This study is looking into whether taking tamsulosin before certain urogynecology surgeries can lower your chances of needing a Foley catheter (a flexible tube that drains urine from the bladder) when you go home. Researchers will compare tamsulosin to a placebo (an inactive substance) to see if tamsulosin helps prevent postoperative urinary retention (POUR). You may be able to join if you are a woman aged 18 or older having surgery for pelvic organ prolapse or incontinence. The main goal is to see if participants can successfully urinate on their own on the day of surgery. The current status of this study is unclear, and it plans to enroll 166 participants.

Study design
This interventional study is designed to compare tamsulosin to a placebo in 166 women.
What's involved
If you join, you would start taking either tamsulosin or a placebo 5-7 days before your surgery. The study will assess your ability to urinate on the day of surgery.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome is measured on the day of surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06843538

Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

Recruiting
PHASE3Ages 18+InterventionalPrevention
TriHealth Inc.
~166 participants
Updated 2025-02-25 on ClinicalTrials.gov
What's tested:TamsulosinPlacebo

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Voiding trial on postoperative day 0
Measured over Day of surgery
Postoperative Urinary Retention (POUR)
1 sites across 1 states
Ohio1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Any surgery involving a non-urogynecologist
Patients already on an alpha blocker
Baseline hypotension
History of syncope
Postural orthostatic tachycardia syndrome (POTS)
Non-English speaker or interpreter unavailable for Spanish-speaking patient
Impaired cognition impeding proper consenting
Any other medical contraindication for tamsulosin use
History of urinary retention requiring continuous or intermittent catheterization
Patients consented for the study but then due to intraoperative complication, routine voiding trial no longer indicated due to requiring indwelling catheter or intermittent catheterization on discharge will be excluded from primary outcome analysis
Pregnancy
  • Voiding trial on postoperative day 0Day of surgery

    Whether or not patients pass or fail their postoperative voiding trial